We are live on ! Find out more
FBC

Fairfield, Bush & Co Portfolio holdings

AUM $180M
1-Year Est. Return 39.51%
This Fund
S&P 500
This Quarter Est. Return
+10.38%
1 Year Est. Return
+39.51%
3 Year Est. Return
+100.99%
5 Year Est. Return
+139.5%
10 Year Est. Return
+536.52%
AUM
$356M
AUM Growth
+$16M
Cap. Flow
-$15.2M
Cap. Flow %
-4.28%
Top 10 Hldgs %
38.78%
Holding
163
New
6
Increased
24
Reduced
67
Closed
4

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$2.11M
2
ADBE icon
Adobe
ADBE
+$1.47M
3
CSCO icon
Cisco
CSCO
+$1.12M
4
INTC icon
Intel
INTC
+$582K
5
WPC icon
W.P. Carey
WPC
+$447K

Top Sells

Rank Stock Value
1
NEOG icon
Neogen
NEOG
+$2.65M
2
IFF icon
International Flavors & Fragrances
IFF
+$1.91M
3
MSFT icon
Microsoft
MSFT
+$1.31M
4
JPM icon
JPMorgan Chase
JPM
+$1.09M
5
LOW icon
Lowe's Companies
LOW
+$1.04M

Sector Composition

Rank Sector Weight
1 Technology 21.7%
2 Healthcare 15.65%
3 Consumer Discretionary 13.04%
4 Consumer Staples 12.86%
5 Financials 11.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BA icon
126
Boeing
BA
$171B
$327K 0.09%
880
-100
-10% -$35.1K
AVY icon
127
Avery Dennison
AVY
$13B
$325K 0.09%
3,000
– –
BNY
128
Bank of New York Mellon
BNY
$106B
$319K 0.09%
6,264
– –
TROW icon
129
T. Rowe Price
TROW
$23.9B
$317K 0.09%
2,901
– –
V icon
130
Visa
V
$684B
$300K 0.08%
2,000
– –
MCHI icon
131
iShares MSCI China ETF
MCHI
$6.32B
$299K 0.08%
5,000
– –
MO icon
132
Altria Group
MO
$114B
$296K 0.08%
4,906
-25
-0.5% -$1.48K
FTS icon
133
Fortis
FTS
$29B
$293K 0.08%
9,024
– –
BLUE
134
DELISTED
bluebird bio
BLUE
$292K 0.08%
154
– –
MET icon
135
MetLife
MET
$61.9B
$282K 0.08%
6,043
– –
ESRX
136
DELISTED
Express Scripts Holding Company
ESRX
$281K 0.08%
2,953
– –
NUE icon
137
Nucor
NUE
$58.6B
$261K 0.07%
4,121
-1,450
-26% -$92.8K
ALL icon
138
Allstate
ALL
$68B
$256K 0.07%
2,596
– –
ITW icon
139
Illinois Tool Works
ITW
$82.6B
$246K 0.07%
1,740
– –
TMO icon
140
Thermo Fisher Scientific
TMO
$213B
$244K 0.07%
1,000
– –
VOD icon
141
Vodafone
VOD
$36.3B
$242K 0.07%
+11,171
New +$260K
GS.PRD icon
142
Goldman Sachs Group Inc Series D Preferred Stock
GS.PRD
$1.02B
$239K 0.07%
10,692
-5,000
-32% -$115K
AXDX
143
DELISTED
Accelerate Diagnostics
AXDX
$236K 0.07%
1,029
– –
K
144
DELISTED
Kellanova
K
$231K 0.06%
3,515
– –
ING icon
145
ING
ING
$99.8B
$229K 0.06%
17,681
-4,300
-20% -$60.3K
LUMN icon
146
Lumen
LUMN
$6.57B
$227K 0.06%
10,700
– –
JCI icon
147
Johnson Controls International
JCI
$88.8B
$219K 0.06%
6,267
– –
AGN
148
DELISTED
Allergan plc
AGN
$208K 0.06%
+1,092
New +$201K
MDU icon
149
MDU Resources
MDU
$4.17B
$207K 0.06%
21,207
– –
WMB icon
150
Williams Companies
WMB
$87.5B
$201K 0.06%
+7,406
New +$215K
3 4 5
6
7

Similar funds

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
V
ViaWealth Leawood, Kansas $180M AUM 20.16% 1-Year Est. Return
RVM
Robinson Value Management San Antonio, Texas $180M AUM 24.17% 1-Year Est. Return
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return

Fairfield, Bush & Co's Q3 2018 Portfolio in Review

As of Q3 2018, Fairfield, Bush & Co held 163 positions worth $356M, up 4.7% from $340M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Fairfield, Bush & Co withdrew a net $15.2M in Q3 2018, closing 4 positions and reducing 67 holdings. Its most notable exit was Athenahealth, Inc., an estimated $756K position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Fairfield, Bush & Co opened a new position in Adobe worth $1.54M.

  • Fairfield, Bush & Co's largest Q3 2018 buy was Adobe: 5,710 shares worth $1.54M.
  • Fairfield, Bush & Co added most to Apple in Q3 2018, an estimated $2.11M increase.
  • Fairfield, Bush & Co's biggest Q3 2018 reduction was Neogen, cutting an estimated $2.65M.
  • Fairfield, Bush & Co fully exited Athenahealth, Inc. in Q3 2018, selling an estimated $756K.
  • Fairfield, Bush & Co's ten largest holdings make up 39% of its $356M portfolio in Q3 2018.
  • Fairfield, Bush & Co opened 6 new positions and closed 4 in Q3 2018.
  • Fairfield, Bush & Co's portfolio value rose 4.7% quarter-over-quarter to $356M.

Based on Fairfield, Bush & Co's 13F filing for Q3 2018, filed 13 Nov 2018.